Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Asthma
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Triple (Participant, Care Provider, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 70 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03953300
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Mario Castro, MD University of Kansas School of Medicine 3901 Rainbow Blvd. Kansas City, KS 66160, United States of America (USA)
Get Well Soon